|
2024 Conference Publication LobSig4 is a superior and readily implementable ILC-focussed prognostic biomarker setKalinowski, Lauren, Kutasovic, Jamie, Srihari, Sriganesh, Feng, Yufan, Lal, Samir, Ferguson, Kaltin, Chittoory, Haarika, Sokolova, Anna, Lim, Malcolm, De Croft, Priyakshi Kalita, Lakhani, Sunil, Simpson, Peter and Reed, Amy McCart (2024). LobSig4 is a superior and readily implementable ILC-focussed prognostic biomarker set. San Antonio Breast Cancer Symposium 2023, San Antonio, TX United States, 5-9 December 2023. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/1538-7445.sabcs23-po3-15-09 |
|
2024 Conference Publication Evaluating the accuracy of 18F-FDG PET-MRI scan in detecting regional lymph node disease in high risk breast cancer patients: PETAL studyMurugappan, K., Lakhani, S., Ung, O., Kenny, L., Thomas, P., Rezai, S., Niland, C., McMahon, K. and Tran, S. (2024). Evaluating the accuracy of 18F-FDG PET-MRI scan in detecting regional lymph node disease in high risk breast cancer patients: PETAL study. Australasian Society for Breast Disease 13th Scientific Meeting, Adelaide, SA, Australia, 14-16 September 2023. London, United Kingdom: Churchill Livingstone. doi: 10.1016/j.breast.2023.103631 |
|
2023 Conference Publication HER2 in situ hybridization testing in breast cancer: applying algorithm-assisted assessment to reduce interobserver variability in difficult casesGough, Madeline, Liu, Cheng, Srinivasan, Bhuvana, Wilkinson, Lisa, Dunk, Louisa, Yang, Yuanhao, Tuffaha, Haitham, Kryza, Thomas, Hooper, John D., Lakhani, Sunil R. and Snell, Cameron Edward (2023). HER2 in situ hybridization testing in breast cancer: applying algorithm-assisted assessment to reduce interobserver variability in difficult cases. 2023 ASCO Annual Meeting, Chicago, IL United States, 2-6 June 2023. Alexandria, VA United States: American Society of Clinical Oncology. doi: 10.1200/jco.2023.41.16_suppl.e13561 |
|
2023 Conference Publication Branchioma: A Series of 23 Cases Illustrating Frequent Loss of the Retinoblastoma 1 (Rb1)Baneckova, Martina, Thompson, Lester, Hyrcza, Martin, Vanecek, Tomas, Grossmann, Petr, Michal, Michael, Hajkova, Veronika, Taheri, Touraj, Rupp, Niels, Suster, David, Lakhani, Sunil, Nikolov, Dimitar Hadzi, Skalova, Alena, Michal, Michal and Agaimy, Abbas (2023). Branchioma: A Series of 23 Cases Illustrating Frequent Loss of the Retinoblastoma 1 (Rb1). 112th Annual Meeting of the United States and Canadian Academy of Pathology (USCAP), New Orleans, LA, United States, 11-16 March 2023. Amsterdam, Netherlands: Elsevier. |
|
2023 Conference Publication Diff-Quik smears from EBUS TBNA procedures: Evaluating measures of tumour cellularity and feasibility of whole genome sequencing (WGS)Fielding, David, Dalley, Andrew, Singh, Mahendra, Nandakumar, Lakshmy, Lakis, Vanessa, Chittoory, Haarika, Bashirzadeh, Farzad, Bint, Michael, Pahoff, Carl, Son, Jung, Hodgson, Alan, Sharma, Sowmya, Godbolt, David, Coleman, Kylie, Whitfield, Lenore, Waddell, Nicola, Lakhani, Sunil, Nones, Katia, Hartel, Gunter and Simpson, Peter (2023). Diff-Quik smears from EBUS TBNA procedures: Evaluating measures of tumour cellularity and feasibility of whole genome sequencing (WGS). 26th Congress of the Asian Pacific Society of Respirology Above and Beyond, Seoul, Korea, 17-20 November 2022. Richmond, VIC, Australia: John Wiley & Sons. doi: 10.1111/resp.14433 |
|
2021 Conference Publication Implementation of precision oncology for breast cancer care in Brisbane: Q-IMPROvEMcCart Reed, Amy, McCurry, Therese, Simpson, Peter, Inglis, Po-Ling, Ung, Owen, Murugappan, Kowsalya, Waddell, Nic, Snell, Cameron, Woodward, Natasha, Middleton, Kathryn, Walpole, Euan, O'Byrne, Ken, Cuff, Katharine, Andelkovic, Vladimir, Roberts, Kate, Steinke, Karin, Santamaria, Gorane, McCarthy, Nicole, Mar Fan, Helen, Kalinowski, Lauren and Lakhani, Sunil (2021). Implementation of precision oncology for breast cancer care in Brisbane: Q-IMPROvE. Brisbane Cancer Conference , Brisbane, QLD Australia, 25-26 Nov 2021. |
|
2021 Conference Publication Implementation of precision oncology for breast cancer care in Brisbane: Q-IMPROvEMcCart Reed, Amy, McCurry, Therese, Simpson, Peter, Inglis, Po-ling, Ung, Owen, Murugappan, Kowsalya, Waddell, Nic, Snell, Cameron, Woodward, Natasha, Middleton, Kathryn, Walpole, Euan, O'Byrne, Ken, Cuff, Katharine, Andelkovic, Vlad, Roberts, Kate, Steinke, Karin, Santamaria, Gorane, McCarthy, Nicole, Mar Fan, Helen, Kalinowski, Lauren and Lakhani, Sunil (2021). Implementation of precision oncology for breast cancer care in Brisbane: Q-IMPROvE. Herston Symposium, Brisbane, QLD Australia, September 2021. |
|
2021 Conference Publication OlympiA: A phase III, multicenter, randomized, placebo-controlled trial of adjuvant olaparib after (neo)adjuvant chemotherapy in patients with germline BRCA1/2 mutations and high-risk HER2-negative early breast cancerTutt, Andrew, Garber, Judy Ellen, Kaufman, Bella, Viale, Giuseppe, Fumagalli, Debora, Rastogi, Priya, Gelber, Richard D., de Azambuja, Evandro, Fielding, Anitra, Gelpi, Judith Balmana, Gelmon, Karen A., Baker, Nigel, Arahmani, Amal, Senkus-Konefka, Elzbieta, Mc Fadden, Eleanor, Karantza, Vassiliki, Lakhani, Sunil R., Yothers, Greg, Campbell, Christine and Geyer, Charles E. (2021). OlympiA: A phase III, multicenter, randomized, placebo-controlled trial of adjuvant olaparib after (neo)adjuvant chemotherapy in patients with germline BRCA1/2 mutations and high-risk HER2-negative early breast cancer. Virtual Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Electr Network, Jun 04-08, 2021. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/JCO.2021.39.15_suppl.LBA1 |
|
2020 Conference Publication Characterising clinicopathological and biological parameters predictive of outcome for patients diagnosed with invasive lobular carcinomaSimpson, P., Reed, A. McCart, Kutasovic, J., Coorey, C., Kuo, L., Nguyen, H., Pei, W., Ong, J., Sokolova, A., Evans, E., Porter, A. and Lakhani, S. (2020). Characterising clinicopathological and biological parameters predictive of outcome for patients diagnosed with invasive lobular carcinoma. ESMO Breast Cancer Virtual Meeting, Online, 23-24 May 2020. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.annonc.2020.03.186 |
|
2020 Conference Publication Remodelling of calcium influx pathways in breast cancer associated fibroblastsSadras, Francisco, Stewart, Teneale A., Robitaille, Melanie, Peters, Amelia A., Kalita-de Croft, Priyakshi, Soon, Patsy, Saunus, Jodi M., Lakhani, Sunil R., Roberts-Thomson, Sarah J. and Monteith, Gregory R. (2020). Remodelling of calcium influx pathways in breast cancer associated fibroblasts. 2019 San Antonio Breast Cancer Symposium, San Antonio, TX United States, 10-14 December 2019. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/1538-7445.sabcs19-p6-06-15 |
|
2020 Conference Publication Calcium communication in an in vitro model of breast cancer brain metastasesChalmers, Silke B., Sadras, Francisco, Saunus, Jodi , Lakhani, Sunil , Roberts-Thomson, Sarah J. and Monteith, Gregory R. (2020). Calcium communication in an in vitro model of breast cancer brain metastases. ASCEPT-APSA Joint virtual scientific meeting 2020, Virtual meeting, 24-26 November 2020. |
|
2019 Conference Publication Dissecting the heterogeneity of metaplastic breast cancer: a morphological, immunohistochemical and genomic analysis of a large cohortReed, A. E. McCart, Kalaw, E., Nones, K., Bettington, M., Lim, M., Bennett, J., Johnstone, K., Kutasovic, J. R., Kazakoff, S., Xu, Q. C., Saunus, J. M., Reid, L. E., Black, D., Niland, C., Ferguson, K., Gresshoff, I., Raghavendra, A., Liu, J. C., Kalinowski, L., Reid, A. S., Davidson, M., Pearson, J. V., Yamaguchi, R., Harris, G., Tse, G., Papadimos, D., Pathmanathan, R., Pathmanathan, N., Tan, P. H. ... Lakhani, S. R. (2019). Dissecting the heterogeneity of metaplastic breast cancer: a morphological, immunohistochemical and genomic analysis of a large cohort. San Antonio Breast Cancer Symposium, San Antonio, TX, United States, 4-8 December 2018. Philadelphia, PA, United States: American Association for Cancer Research. doi: 10.1158/1538-7445.SABCS18-P3-08-03 |
|
2019 Conference Publication LobSig, a prognostic signature for Invasive Lobular CarcinomaMcCart Reed, Amy E., Lal, Samir, Kutasovic, Jamie R., Wockner, Leesa, Robertson, Alan, de Croft, Priyakshi Kalıta, Dalley, Andrew, Coorey, Craig P., Kuo, Luyu, Ferguson, Kaltin, Niland, Colleen, Miller, Gregory, Johnson, Julie, Reid, Lynne E., Males, Renique, Saunus, Jodi M., Chenevix-Trench, Georgia, Coin, Lachlan, Lakhani, Sunil R. and Simpson, Peter T. (2019). LobSig, a prognostic signature for Invasive Lobular Carcinoma. 7th International PacRim Breast and Prostate Cancer Meeting, Barossa Novotel, South Australia, Australia, 17-20 March 2019. |
|
2019 Conference Publication Remodeling of calcium influx pathways in models of cancer associated fibroblasts in breast cancerMonteith, Greg, Sadras, Francisco, Stewart, Teneale, Robitaille, Melanie, Kalita-de Croft, Priyakshi, Soon, Patsy, Saunus, Jodi, Lakhani, Sunil and Roberts-Thomson, Sarah (2019). Remodeling of calcium influx pathways in models of cancer associated fibroblasts in breast cancer. AACR Annual Meeting on Bioinformatics, Convergence Science, and Systems Biology, Atlanta, GA United States, 29 March - 3 April 2019. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/1538-7445.SABCS18-99 |
|
2019 Conference Publication Innovation in diagnosis and treatment of brain metastases using multifunctional nanomedicinesSaunus, J. M., Lim, M., Puttick, S., Croft, P. Kalita-de, Houston, Z. H., Jones, M. L., Latter, M. J., Campbell, L. C., Thomas, P., Jeffree, R. L., Rose, S. E., Mahler, S. M., Thurecht, K. J., Scott, A. M. and Lakhani, S. R. (2019). Innovation in diagnosis and treatment of brain metastases using multifunctional nanomedicines. San Antonio Breast Cancer Symposium, San Antonio, Texas, 4-8 December 2018. Philadelphia, PA, United States: American Association for Cancer Research. doi: 10.1158/1538-7445.SABCS18-P1-19-02 |
|
2019 Conference Publication Assessment of Ca2+ channels and pumps in brain-seeking breast cancer cell linesLim, Darren Z. R. , Chalmers, Silke B. , Robitaille, Melanie , Saunus, Jodi M. , Lakhani, Sunil R. , Roberts-Thomson, Sarah J. and Monteith, Gregory R. (2019). Assessment of Ca2+ channels and pumps in brain-seeking breast cancer cell lines. ASCEPT-PAGANZ Joint Scientific Meeting, Queenstown, New Zealand, 25-29 November 2019. Hamilton Central, QLD, Australia: ASCEPT. |
|
2019 Conference Publication Using whole genome sequencing and somatic mutation signatures to unravel insight into familial breast cancer aetiologySimpson, P., Nones, K., Johnson, J., Newell, F., Patch, A-M, Thorne, H., Kazakoff, S., De Luca, X., Parsons, M., Ferguson, K., Reid, L., Reed, A. McCart, Srihari, S., Lakis, V., Davidson, A., Mukhopadhyay, P., Holmes, O., Xu, Q., Wood, S., Leonard, C., Beasley, J., Degasperi, A., Nik-Zainal, S., Ragan, M., Spurdle, A., Khanna, K. K., Lakhani, S., Pearson, J., Chenevix-Trench, G. and Waddell, N. (2019). Using whole genome sequencing and somatic mutation signatures to unravel insight into familial breast cancer aetiology. San Antonio Breast Cancer Symposium, San Antonio, TX, United States, 4-8 December 2018. Philadelphia, PA, United States: American Association for Cancer Research. doi: 10.1158/1538-7445.SABCS18-P5-10-01 |
|
2018 Conference Publication Expression of ARGLU and FBXL3 is highly prognostic for invasive lobular carcinomaCoorey, Craig, Lal, Samir, Kutasovic, Jamie, Niland, Colleen, Ferguson, Kaltin, Kuo, Lu Yu, Reid, Lynne, Evans, Elizabeth, Porter, Alan, Lakhani, Sunil, McCart Reed, Amy and Simpson, Peter (2018). Expression of ARGLU and FBXL3 is highly prognostic for invasive lobular carcinoma. Pathology Update 2018, Sydney, NSW Australia, 2-4 March 2018. London, United Kingdom: Lippincott Williams & Wilkins. doi: 10.1016/j.pathol.2017.12.166 |
|
2018 Conference Publication Proteomic analysis of the mouse brain stromal microenvironment: a milieu intérieur of metabolic reprogrammingKalita de Croft, Priyakshi , Straube, Jasmin , Al-Ejeh, Fares , M Saunus,Jodi and R Lakhani, Sunil (2018). Proteomic analysis of the mouse brain stromal microenvironment: a milieu intérieur of metabolic reprogramming. 30th Lorne Cancer Conference 2018, Lorne, Victoria, Australia, 8th-11th February, 2018. |
|
2017 Conference Publication Investigating the HER2-3 dimer as a theranostic target in brain metastasesSaunus, J. M., Croft, P. K.-D., Lee, F. T., Al-Ejeh, F., Lim, M., Ensbey, K., Niland, C., Jeffree, R. L., Thomas, P., Day, B. W., Rose, S., Scott, A. M. and Lakhani, S. R. (2017). Investigating the HER2-3 dimer as a theranostic target in brain metastases. 16th Biennial Congress of the Metastasis Research Society, Chengdu, China, 16-20 September 2016. Dordrecht, Netherlands: Springer. doi: 10.1007/s10585-017-9843-0 |
